Songjiang Ma - 02 Jan 2025 Form 4/A - Amendment Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role: President, Director
Signature: /s/ Songjiang Ma
Issuer symbol: GYRE
Transactions as of: 02 Jan 2025
Net transactions value: -$9,871
Form type: 4/A - Amendment
Filing time: 10 Jan 2025, 16:01:48 UTC
Date Of Original Report: 06 Jan 2025
Previous filing: 02 Jan 2025
Next filing: 08 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GYRE	Common Stock	Sale	$9,871	-833	-0.03%	$11.85	2,918,467	03 Jan 2025	By Spouse	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	This Form 4 amends the Form 4 filed on January 6, 2025 to reflect the correct transaction date as of January 3, 2025. The original filing incorrectly reported the transaction date as of January 3, 2024.